Nurix Receives $2,075,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=29f51730-b08e-4999-b0cd-fe3112185c5d
Date
1/3/2014
Company Name
Nurix
Mailing Address
1700 Owens Street San Francisco, CA 94158
Company Description
The company is focused on the discovery and development of small molecule inhibitors of ubiquitin ligases to treat a broad range of proliferative and degenerative diseases.
Website
http://www.nurix-inc.com
Transaction Type
Venture Equity
Transaction Amount
$2,075,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes are to be used for working capital. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
M&A Terms
Venture Investor
Undisclosed